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Available online at www.sciencedirect.comChromatin structure plays an essential role during gene
expression regulation not only in the case of the host cellular
genome, but also during the viral life cycle. Epigenetic
chromatin marks thereby define, whether a gene promoter is
accessible for the transcription machinery or whether a
repressive heterochromatin state is established. The
heterochromatin-mediated repression of lytic viral genes
results in viral latency, enabling the virus to persist dormant
without being recognized by the host immune system, but
keeping the potential for reactivation. Arising new systems
biology approaches are starting to uncover an unexpected
multiplicity and variety of non-coding (nc)RNAs playing
important roles during chromatin structure control, likely
constituting a novel layer in epigenetic regulation. In this review
we give an overview of chromatin-regulatory viral and host
cellular ncRNAs and their links to viral latency.
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Introduction
The shift from lytic to latent infection represents an
important viral mechanism to escape the host immune
system. Viral latency is associated with the transcriptional
repression of genes involved in lytic infection, resulting in
a dormant viral genome, which remains competent for
reactivation. Often this dormant state is maintained by
the expression of few latency-associated viral gene pro-
ducts [1,2].
During the last decades, chromatin structural dynamics
have gained increasing attention during the establish-
ment of both episomal [3] and proviral latency [4,5].
Upon initial infection, viral DNA — either episomalPlease cite this article in press as: Eilebrecht S, et al.: Non-coding RNAs: novel players in c
j.coviro.2013.04.001
www.sciencedirect.com DNA or integrated proviral DNA — is packed by host
cellular chromatin. Epigenetic modifications, such as
histone acetylation, histone methylation or DNA methyl-
ation alter this chromatin structure and thus determine the
availability of gene promoters for the transcription machin-
ery [6]. The chromatin state leading to viral latency is
believed to depend on host cellular factors and, in the case
of retroviruses, on the site of integration [7].
Recently, non-coding RNAs such as micro (mi)RNAs
[8,9], long non-coding (lnc)RNAs [10–12] and natural
antisense transcripts (NATs) [13,14] have emerged as
being significantly involved in the epigenetic regulation
of chromatin structure. Here we introduce the most
important chromatin-modifying complexes involved in
viral latency and give an overview of host cellular and
viral ncRNAs impacting their activity, thus likely being
important factors during latency establishment.
Chromatin dynamics associated with viral
latency
Numerous mechanisms have been proposed to be
involved in establishing and maintaining viral latency.
These mechanisms depend on the virus type, the chro-
matin environment, transcriptional interference, the lack
of cellular or viral activators or the presence of host
repressors. Transcriptional repression that induces viral
latency is commonly associated with the epigenetic silen-
cing of viral promoters [15] (Figure 1). Here, we briefly
present the currently known epigenetic mechanisms that
are responsible for the establishment and persistence of
episomal and proviral latency.
Chromatin regulation during episomal latency
An extensively studied example for episomal latency is
established by the herpes virus family, comprising herpes
simplex virus (HSV1). The epigenetic regulation of latent
HSV1 gene expression relies on posttranslational histone
modifications but not on DNA methylation [16–18].
Establishment of latency is associated with the recruit-
ment of several proteins, including HDACs and poly-
comb-repressive complex 2 (PRC2) components, to lytic
gene promoters [16,18]. Upon viral reactivation, HCF-1, a
component of the SET1 and MLL1 HMT complexes,
recruits LSD1 and induces H3K4 trimethylation and
transcriptional activation of the HSV promoter [19–21].
Chromatin regulation during proviral latency
Proviral latency is established by the family of
retroviruses, which includes HIV-1. Upon reversehromatin-regulation during viral latency, Curr Opin Virol (2013), http://dx.doi.org/10.1016/
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Chromatin structure and viral latency. (a) Schematic representation of transcription-repressive heterochromatin at lytic viral promoters, supporting the
establishment of viral latency: the posttranslational dimethylation (Me2) or trimethylation (Me3) of histone H3 lysine residues 27 and 9 (H3K27/H3K9)
and histone H4 lysine residue 20 (H4K20) as well as the direct methylation of CpG islands (MeCpG) within gene promoters are predominantly
associated with transcriptional silencing. Host cellular histone methyltransferases (HMTs) and histone demethylases (HDMs) are responsible for
the methylation and demethylation of histone tails, respectively, while DNA methyltransferases (DNMTs) catalyze the methylation of CpG islands.
(b) Schematic view of actively transcribed euchromatin: the trimethylation (Me3) of histone H3 lysine residue 4 (H3K4) and the monomethylation (Me) of
arginine residue 3 (H3R3) as well as the acetylation (Ac) of histone H3 lysine residues 9 and 14 (H3K9, H3K14) and histone H4 lysine residues 5, 8, 12
and 16 (H4K5, H4K8, H4K12, H4K16) are predominantly associated with active transcription. Besides HMTs and HDMs, histone acetyltransferases
(HATs) and histone deacetylases (HDACs) are involved in the setting and erasing of these chromatin marks, respectively. Also a decreased binding of
the linker histone H1 is involved in chromatin remodeling.transcription, the retroviral genome is integrated into the
host cellular genome, where it either resides transcrip-
tionally active or dormant, leading to virion production or
latency, respectively. Epigenetic silencing of viral tran-
scription constitutes the major mechanism involved in
both establishing and maintaining latency and, in contrast
to episomal latency, relies on both DNA methylation and
histone modifications [5,22] (Figure 1). In microglial cells,
the viral reservoirs in the CNS, we have shown that the
cellular proteins CTIP2 and LSD1 synergistically repress
HIV-1 transcription [23,24]. Indeed, CTIP2 recruits
HDAC1, HDAC2 and SUV39h1, leading to H3K9 dea-
cetylation and trimethylation, respectively [24]. Surpris-
ingly, LSD1 recruits hSET1 and WDR5, two members of
the human complex proteins associated with Set1
(hCOMPASS), to trimethylate H3K4 [23]. Association
of both H3K4me3 and H3K9me3 epigenetic marks with
LSD1 recruitment may thus constitute a new level of
eukaryotic gene regulation. Such a gene repression linked
to H3K4me3 has been proposed to prevent the expression
of cryptic promoters [25,26]. This is strengthened by the
findings that HIV-1 preferentially integrates into active
genes and therefore could be considered as a cryptic gene.Please cite this article in press as: Eilebrecht S, et al.: Non-coding RNAs: novel players in c
j.coviro.2013.04.001
Current Opinion in Virology 2013, 3:1–7 Interestingly and as described for HSV, a PRC2 complex
is involved in epigenetic silencing of HIV-1 by trimethy-
lation of H3K27 [27].
Non-coding RNAs in chromatin regulation
During the last years, an increasing number of ncRNAs
has emerged being potently involved in chromatin struc-
tural dynamics, acting as recruiting factors, scaffolds or
decoys for epigenetic chromatin-modifying enzymes [28].
While certain miRNAs recruit epigenetic regulators via
sequence-specific interactions with their target genes, the
regulatory mechanisms utilized by lncRNAs are classified
into cis and trans (Figure 2) [28]. Here we focus on trans-
acting host lncRNAs, viral lncRNAs including long anti-
sense transcripts and viral miRNAs.
Trans-acting long non-coding RNAs
In contrast to miRNAs, lncRNAs predominantly exert
their function via intramolecular secondary structure for-
mation, enabling them to specifically bind cellular inter-
action partners. They can be classified according to their
locus and orientation with respect to the surrounding
protein-coding genes.hromatin-regulation during viral latency, Curr Opin Virol (2013), http://dx.doi.org/10.1016/
www.sciencedirect.com
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Cis-regulation versus trans-regulation. (a) In a cis-regulatory mechanism
the expression of the ncRNA is directly correlated with the expression of
a neighboring gene on the same allele (adapted from Guttman and Rinn
[28]). (b) Trans-regulation is believed to be a more general mechanism,
which can affect the expression of distant genes (1) or genes located on
the other allele (2). Also the expression of neighboring genes can be
affected (3), but such an effect here is indirect and involves mediating
factors. Thus, apart from cis-regulatory host lncRNAs affecting
chromatin structure directly at the site of retroviral integration and apart
from viral lncRNAs, lncRNA candidates affecting chromatin structure
during episomal and proviral latency are likely to act in trans.A recently discovered prominent long intergenic
(li)ncRNA is the HOX antisense intergenic RNA
(HOTAIR), which is transcribed in antisense orientation
from the HOXC locus [29]. HOTAIR interacts with
PRC2 and mediates PRC2-catalyzed H3K27 methylation
at the HOXD locus in trans. HOTAIR is constitutively
overexpressed in breast cancer cells, thereby inducing a
re-targeting of PRC2, leading to genome-wide altered
gene expression [30]. RNA immunoprecipitation-
sequencing (RIP-seq) studies have revealed more than
9000 PRC2-interacting RNAs, including promoter-associ-
ated transcripts and lincRNAs transcribed from all over
the genome, advancing the regulation of PRC2-mediated
chromatin-remodeling to a large variety of ncRNAs
[31]. More recent studies have shown HOTAIR to
act as a scaffold between PRC2 and the HDM LSD1,
which is believed to coordinate H3K27 methylation and
H3K4 demethylation to silence target genes [32]
(Figure 3a). Genome-wide studies have proven about
20% of all cellular lincRNAs to be associated with
PRC2, while about 10% showed an interaction with
CoREST, a compound of LSD1-containing repressorPlease cite this article in press as: Eilebrecht S, et al.: Non-coding RNAs: novel players in c
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associated lincRNAs also associate with PRC2, indicating
that in addition to HOTAIR, many lincRNAs may act as
scaffold for chromatin-modifying activities. 74 lincRNAs
physically interact with various chromatin-modifying
enzymes, among them the HDMs Jarid1b and Jarid1c,
HDAC1, PRC2, the HMTs Eset, Setd8 and Suv39h1 as
well as the HAT TIP60/P400 [34], many of which
have been previously shown to be involved in HIV-1
silencing [5].
Apart from these host cellular lncRNA examples there is
also a variety of viral lncRNAs, which are particularly
expressed either during the latent or the lytic phase of
infection. Among the latter ones, the Kaposi’s sarcoma-
associated herpesvirus (KSHV) encoded polyadenylated
nuclear (PAN) RNA mediates infectious virion pro-
duction [35]. It associates with the HDMs JMJD3 and
UTX and with the HMT MLL2 to target these activities
to the KHSV promoter, leading to increased H3K27
demethylation and H3K4 methylation and thus to tran-
scription activation [36] (Figure 3b). During HSV
latency, only the latency-associated transcript (LAT) is
expressed at high levels and promotes heterochromatin
formation on lytic promoters in a mouse model [37].
However, this potential function of LAT appears to
depend on the animal model used [16] and will need
to be further investigated.
Besides the epigenetic modification of core histones also
the competitive displacement of linker histones has
been implicated in chromatin structural dynamics [38]
(Figure 1). In recent studies we have identified the
essential 7SK ncRNA as decoy for the histone H1
antagonist HMGA1 [39,40] (Figure 3c). Apart from its
function as a repressor of the positive transcription
elongation factor b (P-TEFb) [41], 7SK RNA regulates
the expression of more than 1500 HMGA1 target genes.
Since P-TEFb activity is also critical for efficient HIV-1
genome expression [42], the recent identification of 7SK
complexes containing both HMGA1 and P-TEFb
directly links chromatin-remodeling and transcription
elongation control during HIV latency [43].
Long antisense transcripts and cis regulation
Unlike other lncRNAs, long antisense transcripts usually
regulate their target genes by recruiting epigenetic effec-
tors via a sequence-specific interaction with their comp-
lementary nascent sense mRNA in cis [13] (Figure 3d).
For instance, the antisense ncRNA in the INK4 locus
(ANRIL) overlaps with the locus, which encodes for
the cyclin-dependent kinase inhibitors p15INK4b and
p16INK4a and the p53 regulator ARF. ANRIL affects the
expression of its target genes by two different mechan-
isms: it mediates p15INK4b repression by PRC2-
mediated heterochromatin formation and DNA methyl-
ation [44,45] and it silences p16INK4a expression viahromatin-regulation during viral latency, Curr Opin Virol (2013), http://dx.doi.org/10.1016/
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Non-coding RNAs during chromatin regulation. (a) The lincRNA HOTAIR acts as a scaffold for the HMT PRC2 and the HDM LSD1 in order to silence
gene expression by the coordination of H3K27 trimethylation (H3K27Me3) and demethylation of H3K4 (H3K4Me0). (b) The KHSV-expressed PAN RNA
activates viral gene expression by recruiting the HDMs UTX and JMJD3 and the HMT MLL2, resulting in H3K27 demethylation (H3K27Me0) and H3K4
trimethylation (H3K4Me3), respectively. (c) Cellular 7SK RNA acts as decoy for the histone H1 antagonist and chromatin master regulator HMGA1. (d)
Long antisense transcripts, such as ANRIL, are involved in the recruitment of chromatin-modifying enzymes (PRC2, DNMTs?) to gene promoters by
basepairing with their complementary sequence within the nascent mRNA, resulting in gene expression silencing. (e) HIV-1 TAR is processed by
DGCR8, DROSHA and Rrp6 to miRNAs, which bind to their promoter proximal target sites and are believed to recruit RITS-associated chromatin-
modifiers (HDACs, HP1, Chp1), which subsequently mediate HIV-1 silencing.the recruitment of the HMT EZH2 and PRC1-com-
pound CBX7 [46].
Recent studies have demonstrated antisense transcription
to occur also from the integrated HIV-1 genome [47]. A
long antisense RNA transcribed from the U3 region of the
30 LTR has been detected in infected cells [48].
Though the expression of this ncRNA affects gene
expression in a repressive manner, until now cellular
interaction partners remain unidentified, leaving the
mechanism of gene repression elusive.
Also the target of the antisense transcript itself, the
nascent viral mRNA may directly serve as a cis-regulatory
element. We have recently shown the HIV-1 transacti-
vating response (TAR) structure to bind the chromatin
regulator HMGA1, resulting in diminished HIV genePlease cite this article in press as: Eilebrecht S, et al.: Non-coding RNAs: novel players in c
j.coviro.2013.04.001
Current Opinion in Virology 2013, 3:1–7 expression [49]. In addition to the competitive inhibition
of the interaction with Tat-activated P-TEFb, this
HMGA1/TAR complex might also play important roles
during chromatin remodeling at the viral promoter.
Viral microRNAs
The best characterized pathway of miRNA-mediated
gene repression is posttranscriptional silencing via the
RNA-induced silencing complex (RISC) [50]. Apart from
that, more recent studies have revealed that such short
transcripts can also target epigenetic heterochromatin
formation [51]. By guiding the RNA-induced transcrip-
tional silencing (RITS) complex to their complementary
target sites, these RNAs recruit RITS-associating epige-
netic silencers, such as the HMT Clr4 [52], the DMT
Dnmt3a [53] or HDAC1 [54]. However, even though both
viral and host cellular miRNAs have been shown to affecthromatin-regulation during viral latency, Curr Opin Virol (2013), http://dx.doi.org/10.1016/
www.sciencedirect.com
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there is only little known about miRNAs involved in the
epigenetic regulation of viral target promoters.
In the case of HIV, the TAR element is a source for such
miRNA species. It is recognized and cleaved by Dicer,
producing miRNAs, which silence viral gene expression
by facilitating the recruitment of HDAC1 to their pro-
moter proximal target sites [54]. More recent studies have
shown microprocessor to mediate premature termination
of transcription upon TAR synthesis by recruiting the
termination factors Setx and Xm2. The TAR element is
subsequently cleaved by Drosha and processed by the
exonuclease Rrp6 into miRNAs, which are believed to
direct epigenetic silencing enzymes via the RITS path-
way [56] (Figure 3e).
Conclusions
Viral latency constitutes a serious obstacle for the cure of
viral infection. The antiretroviral treatment (ART) of
HIV infected patients for instance is able to target
actively virus-producing cells, but fails to attack latently
infected cells, necessitating lifelong ART. A better com-
prehension of the mechanisms underlying establishment
and persistence of HIV-1 latency will help to design
therapies based on reactivation of reservoirs, which com-
bined with an improved highly active ART could lead to
a functional cure [57–60]. A repressive chromatin struc-
ture at the viral promoter has emerged as a critical pre-
requisite for latency establishment [15], making host
cellular epigenetic regulators important players during
the silencing of viral gene expression.
Though in most cases a wide range of cell types can be
infected, often certain cell types are more prone to
latency than others, such as CD34+ mononuclear hema-
topoietic progenitor cells in the case of cytomegalovirus
(CMV) [61] or CD4+ T and monocyte–macrophage cells
during HIV-1 infection [60,62], supporting the idea of
cell-specific factors being major players during latency
establishment.
Non-coding RNAs are gaining increasing attention as
scaffolds and recruiting factors for chromatin regulators
and thus may establish a novel, cell type specific layer
during epigenetic regulation. Most of the known com-
plexes involved in the establishment of heterochromatin-
associated viral latency can be globally or specifically
targeted by host cellular and/or viral ncRNAs to gene
promoters. Notably, the expression of ncRNAs differs by
far more than the expression of protein coding genes
when comparing different cell types and tissues, making
them promising candidate players during the chromatin-
mediated establishment of viral latency [63,64].
Deeper insights into ncRNA species specifically
expressed in those cell types, which are prone to viralPlease cite this article in press as: Eilebrecht S, et al.: Non-coding RNAs: novel players in c
j.coviro.2013.04.001
www.sciencedirect.com latency, will be required in order to identify RNAs
participating in the epigenetic repression of viral genes.
Such ncRNAs could represent novel therapeutic targets
in order to eradicate latent viral reservoirs, which could in
turn support ART to cure retroviral infection. Especially
systems approaches applying recent powerful technol-
ogies such as next generation sequencing — as pioneered
by Peng et al. [65] and Chang et al. [66] — RNA-seq,
RIP-Seq or 50mC-Seq will substantially improve the
detection of regulatory ncRNA networks during viral
infection to advance our current knowledge about the
establishment of viral latency and host-pathogen inter-
actions in general [67].
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